SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-039777
Filing Date
2019-11-04
Accepted
2019-11-04 16:05:39
Documents
14
Period of Report
2019-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K myok-8k_20191104.htm   iXBRL 8-K 41316
2 EX-99.1 myok-ex991_15.htm EX-99.1 260575
3 GRAPHIC g0pix2mv5j21000001.jpg GRAPHIC 17233
  Complete submission text file 0001564590-19-039777.txt   451535

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA myok-20191104.xsd EX-101.SCH 5972
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20191104_lab.xml EX-101.LAB 18708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20191104_pre.xml EX-101.PRE 11176
11 EXTRACTED XBRL INSTANCE DOCUMENT myok-8k_20191104_htm.xml XML 3394
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 191189779
SIC: 2834 Pharmaceutical Preparations